CSIMarket


Scynexis inc   (SCYX)
Other Ticker:  
 
 

Scynexis Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics



SCYX Asset Turnover Ratio (Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
Y / Y Asset Change 198.98 % 167.59 % 141.09 % 79.41 % 8.68 %
Y / Y Revenue Change - - - - -
Asset Turnover Ratio (TTM) 0.12 - 0.17 - -
Total Ranking # # # # #
Seq. Asset Change -9.29 % 21.04 % -2.4 % 178.99 % -18.81 %
Seq. Revenue Change - - - - -


Asset Turnover Ratio Comment
Despite revenue increase of 0 % year on year, asset turnover ratio decreased to 0.12 in the third quarter 2021 and remained above company average.

Within Healthcare sector Scynexis inc achieved highest asset turnover ratio. While asset turnover ratio remained unchanged compare to previous quarter at no. .

What is Asset Turnover Ratio?
What is Scynexis Inc Market Share?

Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market # 0

Asset Turnover Ratio Statistics
High Average Low
0.01 0.01 0
(Jun 30 2019)   (Jun 30 2017)







Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2021, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2021 Assets at quarter ending Sep 30 2021
Precipio inc   0.31 $ 8.355  Millions$ 26.570  Millions
Biomarin Pharmaceutical Inc  0.31 $ 1,848.582  Millions$ 5,882.261  Millions
Urogen Pharma Ltd   0.31 $ 39.834  Millions$ 126.948  Millions
Acadia Healthcare Company Inc   0.31 $ 1,573.491  Millions$ 5,046.251  Millions
Biohaven Pharmaceutical Holding Company Ltd   0.31 $ 290.160  Millions$ 940.566  Millions
Kempharm Inc  0.30 $ 28.434  Millions$ 94.407  Millions
Adma Biologics Inc   0.30 $ 68.516  Millions$ 228.699  Millions
Travere Therapeutics Inc   0.30 $ 221.380  Millions$ 744.527  Millions
Orthopediatrics Corp  0.30 $ 92.160  Millions$ 311.253  Millions
Anaptysbio inc  0.29 $ 122.164  Millions$ 415.969  Millions
Repligen Corp  0.29 $ 592.661  Millions$ 2,021.894  Millions
Prestige Consumer Healthcare Inc   0.29 $ 1,021.955  Millions$ 3,533.244  Millions
Nanostring Technologies Inc   0.29 $ 134.475  Millions$ 464.954  Millions
Macrogenics Inc   0.28 $ 115.991  Millions$ 408.065  Millions
Avinger Inc  0.28 $ 10.459  Millions$ 36.808  Millions
Nuwellis Inc   0.28 $ 8.323  Millions$ 29.328  Millions
Aerie Pharmaceuticals Inc   0.28 $ 104.151  Millions$ 368.026  Millions
Avita Medical Inc   0.28 $ 31.192  Millions$ 111.017  Millions
Exact Sciences Corporation  0.28 $ 1,755.521  Millions$ 6,259.595  Millions
Bausch Health Companies Inc   0.28 $ 8,451.000  Millions$ 30,172.500  Millions
Clovis Oncology inc   0.28 $ 156.088  Millions$ 558.655  Millions
Global Blood Therapeutics Inc   0.28 $ 179.945  Millions$ 649.138  Millions
Glaukos Corp  0.28 $ 285.602  Millions$ 1,031.286  Millions
Ionis Pharmaceuticals Inc   0.28 $ 660.731  Millions$ 2,387.567  Millions
Nabriva Therapeutics Plc  0.27 $ 22.094  Millions$ 80.594  Millions
Precigen Inc   0.27 $ 103.235  Millions$ 380.661  Millions
Elanco Animal Health Inc  0.27 $ 4,541.600  Millions$ 16,905.750  Millions
Vir Biotechnology Inc   0.26 $ 284.394  Millions$ 1,080.535  Millions
Clearpoint Neuro Inc   0.26 $ 15.733  Millions$ 61.202  Millions
Dicerna Pharmaceuticals Inc   0.26 $ 192.850  Millions$ 750.452  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

LEAT's Profile

Stock Price

LEAT's Financials

Business Description

Fundamentals

Charts & Quotes

LEAT's News

Suppliers

LEAT's Competitors

Customers & Markets

Economic Indicators

LEAT's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071